Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Phio Pharmaceuticals Inc.

Clinical trials sponsored by Phio Pharmaceuticals Inc., explained in plain language.

Phio Pharmaceuticals Inc. PHIO NASDAQ

Develops RNAi-based therapeutics for cancer.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1

New injection aims to shrink skin tumors before surgery

Disease control Ongoing

This early-stage trial tests a drug called PH-762, injected directly into skin tumors, for people with squamous cell carcinoma, melanoma, or Merkel cell carcinoma. Participants receive four weekly injections into one tumor, then have it surgically removed about two weeks later. T…

Phase: PHASE1 • Sponsor: Phio Pharmaceuticals Inc. • Aim: Disease control

Last updated Jun 27, 2026 09:04 UTC